Login / Signup

Expression and Prognostic Value of Lgr5 in Patients with Recurrent Nasopharyngeal Carcinoma.

Haoyuan XuWanpeng LiXiaole SongHuankang ZhangHuan WangJingjing WangLi HuHouyong LiXicai SunDehui Wang
Published in: International journal of general medicine (2023)
Lgr5 as a CSC marker is a promising therapeutic target and could be employed to predict the survival prognosis of rNPC patients.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • poor prognosis
  • peritoneal dialysis
  • prognostic factors
  • patient reported outcomes
  • free survival